Perimeter Medical Imaging Receives HTX Funding

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in surgery tumour margin assessment, today announced financing support for the next phase of product and clinical development, provided by the Health Technology Commercialization Program through htx.ca - The Health Technology Exchange (HTX) and with the support of Princess Margaret Cancer Centre, a University Health Network hospital. This Program has also been made available through the support of the Ontario Ministry of Research and Innovation (MRI)

HTX is a key partner in the Ontario government's Life Sciences Commercialization Strategy. The overarching Health Technology Commercialization Program (HTCP) created by HTX was made possible by a $21.4M funding commitment from the Government of Ontario through the Ministry of Research and Innovation. The purpose of the program is to strengthen Ontario's medtech cluster by providing early stage company financing, and incentives for multinationals to strengthen their business cases for anchoring global development mandates in Ontario. 

John Soloninka, HTX President & CEO, observed:  "We are starting to see the emergence of a Medical Imaging cluster in Ontario and access to funding is a key element to its continued growth.  HTX is proud to be part of this growing ecosystem. Our investment in a promising emerging company like Perimeter Medical Imaging is a perfect example of how HTX funding can facilitate medtech investment and job growth in Ontario.”

“Access to funding is one of the key challenges facing emerging medtech companies like Perimeter,” said Paul Weber, Perimeter’s President and CEO.  “Funding programs like HTCP are key reasons why Ontario is becoming a leading medical imaging cluster in North America.  This support is allowing Perimeter to accelerate commercialization of products that have a real impact on patient care, and create high value jobs for the region!”

About HTX
From Invention through to Innovation to International Invoice, HTX funding programs and services support emerging and established Ontario-based companies to develop, produce and commercialize innovative market-leading advanced health technologies. For more information about this and other programs, please visit www.htx.ca. HTX is a member of the Ontario Network of Excellence www.oneinnovation.ca

About Perimeter Medical Imaging Inc. 
Perimeter Medical develops, patents, and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTISTM is the only solution that provides clinicians with an ultra high resolution image of the entire surface of the removed tissue specimen, providing accurate information in real time, enabling better decisions and ultimately reducing the need for follow-on 2nd surgeries.   Perimeter is a privately owned Canadian company.  For more information, visit www.perimetermed.com
 

Media Contact
Paul Weber, President and CEO
Perimeter Medical Imaging Inc.
(647) 504-4260
pweber@perimetermed.com


* CAUTION - OTIS is an investigational device limited by Federal (or United States) law to investigational use. 
 

kevin chia